Form 4: Select Medical Director Thomas Scully Receives Restricted Stock Grant

Select Medical Holdings Corp. Director and 10% owner Thomas Scully was granted 14,035 shares of common stock, vesting on July 29, 2026.

Summary

• Thomas Scully, a Director and 10% owner of Select Medical Holdings Corp. (SEM), acquired 14,035 shares of common stock.
• The acquisition occurred on July 29, 2025, and was a grant of restricted stock.
• The granted shares will vest in full on July 29, 2026, the first anniversary of the grant date.
• Following this transaction, Thomas Scully beneficially owns 103,424 shares of common stock.
• The transaction price for the acquired shares was $0, which is typical for a restricted stock grant.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director and significant owner is generally positive as it aligns their interests with long-term shareholder value and serves as a retention incentive. It does not indicate any immediate financial distress or significant negative events.

Positives

• The grant of restricted stock to a Director and 10% owner, Thomas Scully, aligns management and significant shareholder interests with the long-term performance of Select Medical Holdings Corp.
• The vesting schedule, set for July 29, 2026, indicates a commitment to future performance and retention of key personnel.

Negatives

• No specific negative aspects are indicated in this Form 4 filing, which primarily reports an equity grant.

Future Outlook

The restricted stock grant to Thomas Scully is scheduled to vest in full on July 29, 2026, indicating a future milestone for this equity compensation.

Industry Context

Equity grants, such as the restricted stock awarded to Thomas Scully, are a standard practice in the healthcare services industry and broader corporate landscape for executive and director compensation. These grants aim to align the interests of key personnel with long-term shareholder value creation and serve as a retention mechanism.

Related Party Transactions

• The filing details a grant of restricted stock to Thomas Scully, a Director and 10% owner of Select Medical Holdings Corp., which constitutes a related party transaction as part of his compensation.

Stakeholder Impact

• Shareholders: The grant of restricted stock to a director and 10% owner aligns their interests with long-term shareholder value creation, potentially fostering more stable and growth-oriented decision-making.
• Employees: While not directly impacting all employees, such grants to leadership can signal stability and commitment from top management.

Next Steps

• The restricted stock grant will vest in full on July 29, 2026.

Key Dates

Recommendation

This Form 4 filing reports a routine restricted stock grant to an insider, which is a common compensation practice and generally viewed as a positive for aligning interests. However, it does not contain sufficient new information or material changes to warrant a change in investment recommendation based solely on this filing. It reinforces a 'hold' position as it indicates continued insider alignment without significant new catalysts or concerns.

Keywords

Select Medical Holdings Corp, SEM, Thomas Scully, Restricted Stock Grant, Director Compensation, Insider Ownership, Form 4, Equity Grant